EBOLA UPDATE BOARD MEETING Stefano Malvolti 2-3 December 2015, - - PowerPoint PPT Presentation

ebola update
SMART_READER_LITE
LIVE PREVIEW

EBOLA UPDATE BOARD MEETING Stefano Malvolti 2-3 December 2015, - - PowerPoint PPT Presentation

EBOLA UPDATE BOARD MEETING Stefano Malvolti 2-3 December 2015, Geneva www.gavi.org Current epidemics at the end but risks remain for the future 28,599 cases - 11,299 deaths (> 510 deaths in health workers) Sierra Leone : Ebola-free since


slide-1
SLIDE 1

www.gavi.org

EBOLA UPDATE

BOARD MEETING Stefano Malvolti 2-3 December 2015, Geneva

slide-2
SLIDE 2

28,599 cases - 11,299 deaths (> 510 deaths in health workers) Sierra Leone: Ebola-free since November 7th Guinea: last case October 29th. All contacts completed 21-days follow-up period. Liberia: 3 new cases recently emerged Short-term: measures to enable a sustained end to current epidemic avoid reintroduction

  • r re-emergence of Ebola virus

Mid-term: risk of new outbreaks from contacts not properly traced or if virus reintroduced from animal reservoirs or through contact with asymptomatic carriers

Current epidemics at the end but risks remain for the future

Board meeting 2-3 December 2015

2

slide-3
SLIDE 3

Gavi has progresses across the 4 areas of work approved by the Board

3

Restoration of EPI services:

  • Catch-up vaccination campaigns
  • Strengthening national efforts on

routine immunisation

  • Mitigation of loss of confidence in

health care systems

  • Supply Chain upgrades and

restoration (Guinea and Liberia)

  • Co-financing waivers for 2014-15

Recovery of health systems

  • Fast-track reprogramming of

existing HSS grants

  • Doubling of HSS ceilings
  • Approval and disbursement

tailored to meet needs and absorption capacity

Availability of EVD vaccine

  • Working with manufacturers to

ensure availability of vaccine in case of new outbreak and stockpile

Deployment of EVD Vaccine

  • WHO’s Global Ebola Vaccine

Implementation Team preparation

  • f deployment plans for registered

vaccine

Board meeting 2-3 December 2015

slide-4
SLIDE 4

Gavi support helped addressing immediate gaps and preventing other outbreaks

Coverage (Jan-June 2014-2015): 81-46% DTP3 and 69-51% MCV1 63 suspected measles cases in Sept-Oct ‘15 in 6 different counties Dec 14: 1st first round of PIRI Feb 15: 2nd round of PIRI May-June 15: Polio SIA and Measles ORI 9-59m July 15: 2nd round Polio SIA Oct 15: 3rd round Polio SIA

TOTAL BUDGET (US$): 4.1M

Coverage (Jan-June 2014-2015): 85-60% DTP3 and 89-63% MCV1 1,802 Measles cases in Sept-Oct ‘15 1 case of poliomyelitis (Kanakan) QI-QII 15: Measles ORIs (6m-10y) in several districts Aug 15: MenA mass campaign Nov 15: National Measles SIA (9- 59m)

TOTAL BUDGET (US$): 6.1M

Coverage (Jan-June 2014-2015): 100-51% DTP3 and 95-49% MCV1 No outbreaks in Sep-Oct ‘15 Dec 14-Jan 15: 1st and 2nd round of PIRI QI 15: National Measles SIA May-June 15: Polio SIA & Measles (9-59m) campaign July 15: Polio SIA Oct 15: 3rd round Polio SIA

TOTAL BUDGET (US$): 2.4M

Board meeting 2-3 December 2015

4

slide-5
SLIDE 5

Gavi’s role in Ebola response focused on deployment of licensed vaccines

5

2016 2017-8 2015

Zaire (current

  • utbreak)

Other Strains

Ring-vaccination using EUAL-authorised monovalent vaccine according to WHO guidance [Under a PHEIC] Use current lead candidate vaccine in

  • ngoing clinical trials

Deployment of licensed monovalent vaccine(s) in specific population and country at risk based

  • n GEVIT plans

Explore safety and efficacy of new monovalent or multivalent vaccines In scope for Gavi Potential engagement to be discussed in Board retreat

Board meeting 2-3 December 2015

slide-6
SLIDE 6

Lessons learnt open discussion on future

  • utbreak preparedness and response

6

Board meeting 2-3 December 2015

slide-7
SLIDE 7

www.gavi.org

THANK YOU